ColdZyme blocks omicron virus – according to new research
23 June 2022 Regulatory press release ColdZyme blocks omicron virus – according to new research New data from an ongoing in-vitro study shows that Enzymatica’s mouth spray ColdZyme blocks the widespread omicron virus from binding to human cells. This indicates ColdZyme could play an important role against many different coronaviruses, including several SARS-CoV-2 variants. Clinical trials will now be accelerated to further investigate the effect in humans. A research group at the Medical University of Innsbruck, Austria, is currently conducting a multi-